Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cellular and Molecular Biology Letters is Scopus-indexed (Q1, CiteScore 17.1), WoS SCIE, DOAJ. Published by BioMed Central Ltd.
Checked against the index lists dated .
ISSN 1425-8153Verify ISSN ↗1689-1392Verify ISSN ↗
Publisher: BioMed Central Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biochemistry | 22 / 448 | 95th | Q1 |
| Molecular Biology | 29 / 414 | 93rd | Q1 |
| Cell Biology | 27 / 289 | 90th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1996–present, best quartile Q1, CiteScore 17.1.
Cellular and Molecular Biology Letters is Q1 in Biochemistry (rank 22 of 448), Q1 in Molecular Biology (rank 29 of 414) and Q1 in Cell Biology (rank 27 of 289), by CiteScore 2025.
Cellular and Molecular Biology Letters is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 17.1, which places it in quartile Q1 at the 95th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.885, quartile Q1, with an H-index of 80.
The publisher lists an article processing charge of about US$2,890 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Cellular and Molecular Biology Letters is published by BioMed Central Ltd. Its print ISSN is 1425-8153 and its online ISSN is 1689-1392.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Cellular and Molecular Biology Letters has an h-index of 88 and a 2-year mean of 10.23 citations per paper (OpenAlex). Its Scopus CiteScore is 17.1, quartile Q1. On 2-year citations it ranks #13 of 442 Scopus journals in Biochemistry.
Cellular and Molecular Biology Letters published 158 papers in 2025; its busiest recent year was 2024 with 160. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from China (68.4%), United States (5.4%) and France (3.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 22 retracted papers are recorded (8.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.